Effect of omeprazole 20 mg twice daily on duodenograstric and gastro- oesophageal bile reflux in Barrett's oesophagus

Gut

Volumn 43, Issue 5, 1998, Pages 603-606

  Marshall, R E K ^a   Anggiansah, A ^a   Manifold, D K ^a   Owen, W A ^a   Owen, W J ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Bilirubin monitoring; Duodenogastric reflux; Duodenogastro oesophageal reflux; Omeprazole; pH monitoring

Indexed keywords

OMEPRAZOLE;

AMBULATORY MONITORING; ARTICLE; BARRETT ESOPHAGUS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; GASTROESOPHAGEAL REFLUX; HUMAN; PRIORITY JOURNAL; STOMACH PH;

EID: 0031798058     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.5.603     Document Type: Article

References (33)

1. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's oesophagus. Surgery 1995;117:699-704.
2. Nakano K, Konishi H, Noda M, et al. An experimental model of Barrett's oesophagus by bile reflux [abstract]. Gastroenterology 1994;106:A147.
3. Gillen P, Keeling P, Byrne PJ, et al. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988;75: 113-15.
4. Bremner CG, Lynch VP, Ellis FH. Barrett's oesophagus: congenital or acquired? An experimental study of oesophageal mucosal regeneration in the dog. Surgery 1970;68: 209-16.
5. Clark GW, Smyrk TC, Mirvish SS, et al. Effect of gastroduodenal juice and dietary fat un the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol 1994;1:252-61.
6. Flaherty J, Lawlor P, Byrne PJ, et al. Anti-reflux surgery: its role in bile reflux. Br J Surg 1996;83:13.
7. Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-54.
8. Wetscher GJ, Hinder RA, Kretchmar D, et al. Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade. Dig Dis Sci 1996;41: 2166-73.
9. Bechi P, Pucciani F, Baldini F, et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993;38:1297-306.
10. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994;267:G1050-7.
11. Caldwell MT, Byrne PJ, Brazil N, et al. An ambulatory bile reflux monitoring system: an in vitro appraisal. Physiol Meas 1994;15:57-65.
12. Kauer WKH, Burdiles P, Ireland AP, et al. Does duodenal juice reflux into the oesophagus of patients with complicated GORD? Evaluation of a new fibreoptic sensor for bilirubin. Am J Surg 1995;169:98-104.
13. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-32.
14. Bechi P, Falciai R, Baldini F, et al. A new fibreoptic sensor for ambulatory enterogastric reflux detection. Fiberoptic Medical and Flourescent Sensors and Applications 1992; (1648):130-5.
15. Verdu EF, Fraser R, Murphy GM, et al. The origin of nocturnal intragastric pH rises in healthy subjects. Scand J Gastroenterol 1995;30:935-43.
16. Mattioli S, Felice V, Pilotti V, et al. Indications for 24-hour gastric pH monitoring with single and multiple probes in clinical research and practice. Dig Dis Sci 1992;37:1793-801.
17. Attwood SK, Ball CS, Barlow AP, et al. Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus. Gut 1993;34:11-15.
18. Festen HPN, Tuynman HARE, Defize J, et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum pepsinogen I levels. Dig Dis Sci 1986;31:561-6.
19. Lamberts R, Creutzfeldt W, Struber HG, et al. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104:1356-70.
20. Rasmussen L, Oster-Jorgensen E, Qvist N, et al. The effects of omeprazole on interdigestive motility and early postprandial levels of gastrin and secretin. Scand J Gastroenterol 1992;27:119-23.
21. Hunt JN, Ramsbottom N. Effect of gastrin II on gastric emptying and secretion during a test meal. BMJ 1967;4: 386-90.
22. Hamilton SG, Sheiner HJ, Quinlan MF. Continuous monitoring of the effect of pentagastrin on gastric emptying of solid food in man. Gut 1976;17:273-9.
23. Rasmussen L, Oster-Jorgensen E, Qvist N, et al. Short report: a double-blind placebo-controlled trial of omeprazole on characteristics of gastric emptying in healthy subjects. Aliment Pharmacol Ther 1991;5:85-9.
24. Hongo M, Lin YF, Ujiie H, et al. Acid suppression by omeprazole inhibits gastric emptying in normal subjects [abstract]. Gastroenterology 1996;96:A218.
25. Benini L, Castellani G, Bardelli E, et al. Omeprazole causes delay in gastric emptying of meals. Dig Dis Sci 1996;41: 469-74.
26. Horowitz M, Hetzel DJ, Buckle PJ, et al. The effect of omeprazole on gastric emptying in patients with duodenal ulcer disease. Br J Clin Pharmacol 1984;18:791-4.
27. Vinter-Jensen L, Kraglund K, Pedersen SA. A double-blind placebo controlled trial on characteristics of the migrating motor complex in healthy volunteers. Aliment Pharmacol Ther 1989;3:615-20.
28. Pedersen SA, Kraglund K, Vinter-Jensen L. The effects of omeprazole on gastro-oesophageal sphincter pressure, intragastric pH, and the migrating motor complex in fasting healthy subjects. Scand J Gastroenterol 1987;22:725-30.
29. Dent J, Downton J, Heddle R, et al. Effects of omeprazole on peptic oesophagitis and oesophageal motility and pH. Scand J Gastroenterol 1986;118:181.
30. Lind T, Cederberg C, Ekenved G, et al. Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 1983;24:270-6.
31. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialised intestinal metaplasia of cardiac mucosa is a manifestation of gastro-oesophageal reflux disease. Ann Surg 1997;226:522-32.
32. Leite LP, Johnston BT, Just RJ, et al. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996;91:1527-31.
33. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91.